atezolizumab based treatment | nivolumab based treatment | anti-PD-(L)1 | pembrolizumab based treatment | sintilimab based treatment | ||
atezolizumab plus bevacizumab | nivolumab alone | pembrolizumab based treatment | pembrolizumab alone | pembrolizumab plus lenvatinib | sintilimab |